Form 4 for IRD Opus Genetics, Inc.
Accepted 2023-11-03 00:00:00 ET · period of report 2023-11-01 · accession 0001140361-23-051320 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-03 | 2023-11-01 | IRD | Magrath George | CEO | A - Grant | $0.00 | +400.0K | 400.0K | New | $0 |
| D | 2023-11-03 | 2023-11-01 | IRD | Magrath George | CEO | A - Grant | $0.00 | +600.0K | 600.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-01 | A | A | 400,000 | $0.00 | 400,000 | D | — | — | (F1) Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of November 1, 2023. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2023-11-01 | A | A | 600,000 | $0.00 | 600,000 | D | $2.87 · — to 2033-10-31 | 600,000 Common Stock | (F2) The option will vest with respect to 25% on the first anniversary of the grant date, with the remaining shares vesting in equal monthly installments on the last day of each full month over the subsequent 36 months, subject to continuing service. |